Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

Manette A.W. Dinnessen*, Carolien C.H.M. Maas, Sanne H. Tonino, Otto Visser, Eduardus F.M. Posthuma, Nicole M.A. Blijlevens, Marie José Kersten, Pieternella J. Lugtenburg, Avinash G. Dinmohamed

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)1416-1420
Number of pages5
JournalLeukemia
Volume36
Issue number5
Early online date4 Mar 2022
DOIs
Publication statusPublished - May 2022

Bibliographical note

Funding Information: MJK: research support from Kite/Gilead and honoraria and/or travel support from Kite/Gilead, Novartis, Miltenyi Biotech, Roche, BMS/Celgene. SHT: honoraria from Incyte, Takeda, Celgene and travel support form Roche/ Gilead. PJL: research funding from Takeda, Servier, Roche and honoraria for advisory boards from Takeda, Servier, Roche, Genmab, Incyte, Regeneron, Celgene. The other authors have no conflict of interest.

Cite this